Company Overview

KALA BIO, INC.

KALA
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
—M
2024 FY
Net Income
-39M
2024 FY
Shares Outstanding
4M
2024 FY
EPS
-10.15USD
2024 FY
Company Information
SIC Code
2834
CIK Code
1479419
Exchange
Nasdaq
Location
US